Acute mitral chodae rupture in the early postcovid in heavy physical active men. Case series
https://doi.org/10.47529/2223-2524.2022.1.2
Abstract
The opinion that COVID-19 is a greater threat only to the elderly people has changed over the past year. Experience has been accumulated in the development of complications of varying severity in young patients who had optimal health indicators before infection. The consequences of myocarditis are most dangerous, especially in athletes and military personnel. We present a series of clinical cases of spontaneous mitral valve chordae rupture in highly trained middle-aged men in the early post-COVID period. In all cases, the infection proceeded subclinically; SARS-CoV-2 was verified only by analysis for IgM. 1–2 weeks after infection, against the background of a routine training process, patients felt pain in the heart area, which was underestimated. Patients presented for help at 2 and 10 weeks with complaints of reduced endurance and shortness of breath. Echocardiography revealed rupture of one of the chords of the anterior part of the mitral valve against the background of signs of myocarditis with the development of valvular insufficiency of the 1st degree. By the time of treatment, the pathology of other laboratory data and ECG was not observed. The control after 6 months showed in 1 patient a focus of myocardial fibrosis according to MRI, a minimal increase in NT-proBNP, a decrease in exercise tolerance, in 2 patients there was no visible fibrosis, normal NT-proBNP and complete restoration of exercise tolerance, but a decrease in local myocardial deformation according to echocardiography.
About the Authors
Z. N. Sukmarova
P.V. Mandryka Central Millitary Clinical Hospital
Russian Federation
Russian Federation
Zulfiya N. Sukmarova, Ph.D. (Medicine), cardiologist, functional diagnostics doctor
8A, Bolshaya Olenya str., Moscow, 107014
Yu. V. Ovchinnikov
S.M. Kirov Military Medical Academy
Russian Federation
Russian Federation
Yuryi V. Ovchinnikov, M.D., Ph.D. (Medicine), Head of the Department of Emergency Medicine
7, Malaya Cherkizovskaya str., Moscow, 107392
O. M. Larina
Federal Research and Clinical Center of Sports Medicine and Rehabilitation of Federal Medical Biological Agency
Russian Federation
Russian Federation
Olga M. Larina, Ph.D. (Medicine), radiologist, Head of the Department of radiology
5, Bolshaya Dorogomilovskaya str., Moscow, 121059
S. O. Lependin
P.V. Mandryka Central Millitary Clinical Hospital
Russian Federation
Russian Federation
Sergey O. Lependin, surgeon
8A, Bolshaya Olenya str., Moscow, 107014
O. V. Afonina
P.V. Mandryka Central Millitary Clinical Hospital
Russian Federation
Russian Federation
Olga V. Afonina, cardiologist
8A, Bolshaya Olenya str., Moscow, 107014
A. I. Gromov
A.I. Yevdokimov Moscow State University of Medicine and Dentistry
Russian Federation
Russian Federation
Aleksander I. Gromov, M.D., Ph.D. (Medicine), Professor of the Department radiology; Head of the Department of Radiology of the Clinical Hospital “MEDSI”
20/1, Delegatskаya str., Moscow, 127473
5/4, 2nd Botkinsky proezd, Moscow, 125284
References
1. Phelan D., Kim J.H., Elliott M.D., Wasfy M.M., Cremer P., Johri A.M., et al. Screening of Potential Cardiac Involvement in Competitive Athletes Recovering From COVID-19. An Expert Consensus Statement. JACC: Cardiovasc. imaging. 2020;13(12):2635–2652. https://doi.org/10.1016/j.jcmg.2020.10.005
2. Sukmarova Z.N., Simonenko V.B., Ibragimova F.M., Demyanenko A.V. Pericardial effusion as a new specific symptom of SARS-CoV-2. Clinical Medicine (Russian Journal). 2021;99(3):192-197. (In Russ.) https://doi.org/10.30629/0023-2149-2021-99-3-192-197
3. Caforio A.L., Pankuweit S., Arbustini E., Basso C., Gimeno- Blanes J., Felix S.B., et al. Current state of knowledge on aetiology, diagnosis, management, and therapy of myocarditis: a position statement of the European society of cardiology working group on myocardial and pericardial diseases. Eur. Heart J. 2013;34(33):2636– 2648, 2648a–2648d. https://doi.org/10.1093/eurheartj/eht210
4. Rajpal S., Tong M.S., Borchers J., Zareba K.M., Obarski T.P., Simonetti O.P., Daniels C.J. Cardiovascular magnetic resonance findings in competitive athletes recovering from COVID-19 infection. JAMA Cardiol. 2020;6(1):116–118. https://doi.org/10.1001/jamacardio.2020.4916
5. Szekely Y., Lichter Y., Taieb P., Banai A., Hochstadt A., Merdler I., et al. Spectrum of cardiac manifestations in COVID-19: a systematicechocardiographic study. Circulation. 2020;142:342– 353. https://doi.org/10.1161/CIRCULATIONAHA.120.047971
6. Maron B.J., Udelson J.E., Bonow R.O., Nishimura R.A., Ackerman M.J., Estes N.A. 3rd, et al. Eligibility and Disqualification Recommendations for Competitive Athletes With Cardiovascular Abnormalities: Task Force 3: Hypertrophic Cardiomyopathy, Arrhythmogenic Right Ventricular Cardiomyopathy and Other Cardiomyopathies, and Myocarditis: A Scientific Statement From the American Heart Association and American College of Cardiology. Circulation. 2015;132(22):e273–280. https://doi.org/10.1161/CIR.0000000000000239
7. Malek L.A., Marczak M., Milosz-Wieczorek B., Konopka M., Braksator W., Drygas W., Krzywanski J. Cardiac involvement in consecutive elite athletes recovered from Covid- 19: A magnetic resonance study. J. Magn. Reson. Imaging. 2021;53(6):1723–1729. https://doi.org/10.1002/jmri.27513
8. Clark D.E., Parikh A., Dendy J.M., Diamond A.B., George- Durrett K., Fish F.A., et al. COVID-19 Myocardial Pathology Evaluation in AthleTEs with Cardiac Magnetic Resonance (COMPETE CMR). Circulation. 2021;143(6):609–612. https://doi.org/10.1161/CIRCULATIONAHA.120.052573
9. Morgera T., Di Lenarda A., Dreas L., Pinamonti B., Humar F., Bussani R., et al. Electrocardiography of myocarditis revisited: clinical and prognostic significance of electrocardiographic changes. Am. Heart J. 1992;124(2):455–467. https://doi.org/10.1016/0002-8703(92)90613-z
10. Baggish A.L., Battle R.W., Beaver T.A., Border W.L., Douglas P.S., Kramer C.M., et al. Recommendations on the use of multimodality cardiovascular imaging in young adult competitive athletes: a report from the American Society of Echocardiography in Collaboration with the Society of Cardiovascular Computed Tomography and the Society for Cardiovascular Magnetic Resonance. J. Am. Soc. Echocardiogr. 2020;33(5):523–549. https://doi.org/10.1016/j.echo.2020.02.009
11. Aquaro G.D., Habtemicael Y.G., Camastra G., Monti L., Dellegrottaglie S., Moro C., et al. Prognostic value of repeating cardiac magnetic resonance in patients with acute myocarditis. J. Am. Coll. Cardiol. 2019;74(20):2439–2448. https://doi.org/10.1016/j.jacc.2019.08.1061
12. Zimmerman F.H., Mogtader A.H. Ruptured chordae tendineae and acute pulmonary edema induced by exercise. Occurrence in a young man with mitral valve prolapse. JAMA. 1987;258(6):812–813.
13. Huang C., Wang Y., Li X., Ren L., Zhao J., Hu Y., et al. Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. Lancet. 2020;395(10223):497–506. https://doi.org/10.1016/S0140-6736(20)30183-5
14. Tajbakhsh A., Gheibi Hayat S.M., Taghizadeh H., Akbari A., Inabadi M., Savardashtaki A., et al. COVID-19 and cardiac injury: clinical manifestations, biomarkers, mechanisms, diagnosis, treatment, and follow up. Expert Rev. Anti Infect. Ther. 2021 Mar;19(3):345–357. https://doi.org/10.1080/14787210.2020.1822737
15. Gabbay U., Yosefy C. The underlying causes of chordae tendinae rupture: A systematic review. International Journal of Cardiology. 2010;143(2):113–118. https://doi.org/10.1016/j.ijcard.2010.02.011
16. Portugese S., Amital H., Tenenbaum A., Bar-Dayan Y., Levy Y., Afek A., et al. Clinical characteristics of ruptured chordae tendineae in hospitalized patients: primary tear versus infective endocarditis. Clin. Cardiol. 1998;21(11):813–816. https://doi.org/10.1002/clc.4960211106
17. Huang C-H., Chen W-J., Tsai M-S. Exercise-induced Acute Mitral Valve Chordae Rupture. J. Med. Ultrasound. 2013;21(3):159– 162. https://doi.org/10.1016/j.jmu.2013.07.006
18. Castiello T., Georgiopoulos G., Finocchiaro G. COVID- 19 and myocarditis: a systematic review and overview of current challenges. Heart Fail. Rev. 2021;27(1):251–261. https://doi.org/10.1007/s10741-021-10087-9
19. Topol E.J. COVID-19 can affect the heart. Science. 2020;370(6515):408–409. https://doi.org/10.1126/science.abe2813
20. Bhatia R.T., Marwaha S., Malhotra A. Exercise in the severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) era: a question and answer session with the experts endorsed by the section of sports cardiology & exercise of the European Association of Preventive Cardiology (EAPC). Eur. J. Prev. Cardiol. 2020;27(12):1242– 1251. https://doi.org/10.1177/2047487320930596
21. McKinney J., Connelly K.A., Dorian P., Fournier A., Goodman J.M., Grubic N., et al. COVID-19-Myocarditis and Return to Play: Reflections and Recommendations From a Canadian Working Group. Can. J. Cardiol. 2021;37(8):1165–1174. https://doi.org/10.1016/j.cjca.2020.11.007
22. Kim J.H., Levine B.D., Phelan D. Coronavirus disease 2019 and the athletic heart: emerging perspectives on pathology, risks, and return to play. JAMA Cardiol. 2021;6(2):219–227. https://doi.org/10.1001/jamacardio.2020.5890
23. Dores H., Cardim N. Return to play after COVID-19: a sport cardiologist’s view. Br. J. Sports Med. 2020;54(19):1132–1133. https://doi.org/10.1136/bjsports-2020-102482
24. Sukmarova Z., Travin N., Ibragimova F. Acute mitral valve chordae rupture in the early postCOVID in heavy physical active men. One-year observation and tactical issues. In: ESC Preventive Cardiology 2022; 07–09 April 2022; European Association of Preventive Cardiology (EAPC); 2022. Abstract 11317.
Review
For citations:
Sukmarova Z.N., Ovchinnikov Yu.V., Larina O.M., Lependin S.O., Afonina O.V., Gromov A.I. Acute mitral chodae rupture in the early postcovid in heavy physical active men. Case series. Sports medicine: research and practice. 2022;12(1):77-85. (In Russ.) https://doi.org/10.47529/2223-2524.2022.1.2
Views:
2574
Email this article 